Assisted Reproductive Technology in Australia and New Zealand 2023

Assisted Reproduction · Registries and Reporting

Kotevski DP, Newman JE, Chaitarvornkit A, Paul RC, Chambers GM

Published September 2025 National Perinatal Epidemiology and Statistics Unit, UNSW Sydney

Key figures

Measure	Value	Source
Total ART treatment and lab-only cycles, Australia and New Zealand combined, 2023	112,707	Summary
ART treatment and lab-only cycles, Australia, 2023	103,556	Summary
ART treatment and lab-only cycles, New Zealand, 2023	9,151	Summary
Year on year increase in cycle numbers, Australia, 2022 to 2023	3.5%	Summary
Year on year increase in cycle numbers, New Zealand, 2022 to 2023	3.1%	Summary
ART cycles per 1,000 women aged 15 to 44, Australia, 2023	18.7	Summary
ART cycles per 1,000 women aged 15 to 44, New Zealand, 2023	8.6	Summary
Autologous cycles, using a woman's own oocytes or embryos, as a share of fresh and/or thaw cycles, 2023	approximately 94% (105,855)	Summary
Number of women undertaking autologous fresh and/or thaw cycles, 2023	55,783	Summary
Fresh cycles as a share of autologous cycles, 2023	65,283 (61.7%)	Chapter 1
Thaw cycles as a share of autologous cycles, 2023	40,572 (38.3%)	Chapter 1

Measure	Value	Source
Clinical pregnancy rate per initiated ART cycle, excluding donation, surrogacy commissioning and lab-only cycles, 2023	22.6% (24,808)	Chapter 1, Table 1
Live birth rate per initiated ART cycle, excluding donation, surrogacy commissioning and lab-only cycles, 2023	18% (19,741)	Chapter 1, Table 1
Clinical pregnancy rate per embryo transfer, autologous and recipient fresh and thaw cycles, 2023	38.2%	Summary
Live birth rate per initiated autologous fresh cycle, excluding freeze-all cycles, 2023	14.5%	Summary
Live birth rate per autologous fresh cycle reaching embryo transfer, 2023	25.4%	Summary
Live birth rate per initiated autologous thaw cycle, 2023	32.6%	Summary
Live birth rate per autologous thaw cycle reaching embryo transfer, 2023	33%	Summary
Live birth rate per embryo transfer, autologous fresh cycles, women under 30, 2023	38.9%	Summary
Live birth rate per embryo transfer, autologous thaw cycles, women under 30, 2023	38.1%	Summary

Measure	Value	Source
Fresh and thaw embryo transfer cycles, autologous and recipient, 2023	64,646	Chapter 3
Single embryo transfer share of embryo transfer cycles, autologous and recipient, 2023	94.8%	Chapter 3
Double embryo transfer share of embryo transfer cycles, autologous and recipient, 2023	5.1%	Chapter 3

Measure	Value	Source
Total babies born following ART treatment, Australia and New Zealand, 2023	20,417	Summary
Liveborn babies following ART treatment, Australia and New Zealand, 2023	20,174	Summary
Babies born from treatments at Australian ART Units, 2023	18,338 (89.8%)	Summary
Babies born from treatments at New Zealand ART Units, 2023	2,079 (10.2%)	Summary
Liveborn babies that were singletons at term with normal birthweight, 2023	83% (16,741)	Chapter 1
Multiple birth rate following ART, 2023	2.2%	Chapter 1

Measure	Value	Source
Number of women beginning their first ART ovarian stimulation cycle, 2020-2021 cohort	41,543	Summary, cumulative live birth
Cumulative live birth rate by first complete ART cycle, 2020-2021 cohort	39%	Summary, cumulative live birth
Cumulative live birth rate by sixth complete ART cycle, 2020-2021 cohort	59.7%	Summary, cumulative live birth

Measure	Value	Source
Live birth rate per embryo transfer cycle, overall, 2019 to 2023	28% to 30.4%	Summary, five-year trends
Live birth rate per embryo transfer cycle, fresh transfers, 2019 to 2023	25.5% to 25.7%	Summary, five-year trends
Live birth rate per embryo transfer cycle, thaw transfers, 2019 to 2023	29.7% to 32.8%	Summary, five-year trends
Single embryo transfer share of embryo transfer cycles, 2019 to 2023	91.9% to 94.9%	Summary, five-year trends
Multiple birth rate following ART, 2019 to 2023	2.9% to 2.2%	Summary, five-year trends

Our summary of the report's published figures, each citing its table, figure or section. The full report is at the publisher's link.

Assisted Reproduction › Registries and Reporting › National Registry Data

Kotevski et al. 2025, Kotevski 2025